The Novo Nordisk Foundation is an independent Danish enterprise foundation dedicated to supporting scientific, humanitarian, and social initiatives that enhance human life and promote sustainability on our planet. Established in 1924, the foundation operates as a non-profit organization, leveraging funds from its investments to award grants across three primary focus areas: health, sustainability, and the life science ecosystem.

Their initiatives include significant research projects aimed at tackling global health challenges such as infectious diseases, diabetes, and obesity, as well as addressing urgent sustainability issues related to climate change and food security. The foundation also actively invests in advancing the life science ecosystem through partnerships and funding programs, ensuring that vital breakthroughs in health and technology can be developed.

Key projects include the Challenge Programme for enhancing research ecosystems, the Partnership for Education of Health Professionals aimed at reducing health inequity, and the AMR Action Fund to combat antimicrobial resistance. By fostering innovation and collaboration, the Novo Nordisk Foundation is committed to making impactful changes that benefit society at large.